FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the pharmaceutical industry and is a composition effective to enhance energy metabolism comprising at least 0.05 mg of a phosphodiesterase 5 (PDE 5) inhibitor and at least 500 mg leucine and/or at least 200 mg leucine metabolite, wherein the PDE 5 inhibitor contains sildenafil and wherein said leucine metabolite is selected from the group consisting of beta-hydroxymethyl butyrate (HMB), keto-isocaproic acid (KIC), and α-hydroxyisocaproic acid.
EFFECT: invention provides effective enhancement of regulation of energy metabolism, consisting in a synergistic increase in the oxidation of fatty acids in adipocytes and the utilisation of glucose.
24 cl, 27 dwg, 10 tbl, 5 ex
Title |
Year |
Author |
Number |
COMPOSITIONS AND METHODS FOR METABOLIC PATHWAY MODULATION |
2012 |
- Zimel Majkl
- Grindsteff E. Duglas Ii
- Brukbauer Ante
|
RU2631597C2 |
TREATMENT OF LIVER, BILE DUCT AND PANCREATIC DISORDERS |
2017 |
- Nordkild, Peter
- Kjaerulff, Soren
|
RU2740913C2 |
METHODS FOR MODULATING INTESTINAL MICROBIOTA |
2017 |
- Nordkild, Peter
- Wehkamp, Jan
- Kjaerulff, Soren
|
RU2738265C2 |
COMBINATIONS AND COMPOSITIONS CONTAINING FATTY ACIDS AND AMINO ACIDS, THEIR APPLICATION FOR PREVENTION AND DELAY OF PROGRESSING OR TREATMENT OF DIABETES AND DIABETES ASSOCIATED DISEASES AND CONDITIONS, METHOD OF WEIGHT REDUCTION IN MAMMAL, KIT |
2004 |
- Troup Dzhon P.
- Ber Mikhaehl'
|
RU2356247C2 |
CHROMENONE ANALOGUES AS SIRTUIN MODULATORS |
2009 |
- Oulmann Kristofer
- Perni Robert B.
- Vu Chi B.
|
RU2527269C2 |
CANCER MODELS AND CORRESPONDING METHODS |
2014 |
|
RU2707531C2 |
METHOD OF TREATING IL-1BETA-DEPENDENT DISEASES |
2007 |
- Solinger Alan
- Bauer Robert Dzh
- Skannon Patrik Dzh
- Alleva David
|
RU2554747C9 |
METHOD OF TREATING HEPATIC FIBROSES |
2017 |
|
RU2740902C2 |
TREATING DISEASES RELATED TO INSULIN RESISTANCE |
2010 |
- Kolumam Ganesh A.
- Khu Jan'
- Oujan Vehn'Tszjun'
|
RU2537142C2 |
QUINAZOLINONE, QUINOLONE AND RELATED ANALOGUES AS SIRTUIN MODULATORS |
2009 |
- Vu Chi B.
- Oulmann Kristofer
- Perni Robert B.
- Uajt Brajan
|
RU2519779C2 |